https://novapharmanews.com/us/news/fda-approves-first-interchangeable-biosimilars-simponi-simponi-aria 2026-06-11T07:03:28.618Z NovaPharmaNews en 2026-06-11T06:08:45.368Z FDA Approves First Interchangeable Biosimilars to Simponi and Simponi Aria Simponi, Simponi Aria, Immgolis, Immgolis Intri, golimumab, golimumab-sldi, rheumatoid arthritis, ulcerative colitis https://novapharmanews.com/uploads/articles/fda-approves-first-interchangeable-biosimilars-simponi-simponi-aria.webp FDA Approves First Interchangeable Biosimilars to Simponi and Simponi Aria https://novapharmanews.com/us/news/astrazeneca-obesity-push-ultrasound-genetic-medicine-125m 2026-06-11T05:23:55.537Z NovaPharmaNews en 2026-06-11T04:08:10.342Z AstraZeneca expands obesity push as it invests $125M in ultrasound medicine GLP-1, obesity https://novapharmanews.com/uploads/articles/astrazeneca-obesity-push-ultrasound-genetic-medicine-125m.webp AstraZeneca expands obesity push as it invests $125M in ultrasound medicine https://novapharmanews.com/eu/news/chmp-backs-nerandomilast-for-ipf-and-ppf-in-eu 2026-06-11T06:37:50.042Z NovaPharmaNews en 2026-06-11T01:11:36.549Z CHMP backs nerandomilast for IPF and PPF in EU Nerandomilast, Jascayd, idiopathic pulmonary fibrosis, IPF, progressive pulmonary fibrosis, PPF https://novapharmanews.com/uploads/articles/chmp-backs-nerandomilast-for-ipf-and-ppf-in-eu.webp CHMP backs nerandomilast for IPF and PPF in EU https://novapharmanews.com/us/news/fda-drug-approval-what-approval-means-for-pharma-marketing-bd 2026-06-11T04:45:03.925Z NovaPharmaNews en 2026-06-11T01:05:58.154Z FDA Drug Approval: What Approval Means for Pharma Marketing and BD https://novapharmanews.com/uploads/articles/fda-drug-approval-what-approval-means-for-pharma-marketing-bd.webp FDA Drug Approval: What Approval Means for Pharma Marketing and BD https://novapharmanews.com/apac/news/pmda-approves-enhertu-for-her2-low-breast-cancer-in-japan 2026-06-11T00:23:06.082Z NovaPharmaNews en 2026-06-10T22:17:07.203Z PMDA approves ENHERTU for HER2-low breast cancer in Japan https://novapharmanews.com/us/news/fda-salmonella-moringa-leaf-powder-recall-january-2026 2026-06-11T04:45:02.833Z NovaPharmaNews en 2026-06-09T08:05:43.896Z FDA investigates Salmonella in moringa leaf powder, expands recall Salmonella https://novapharmanews.com/uploads/articles/fda-salmonella-moringa-leaf-powder-recall-january-2026.webp FDA investigates Salmonella in moringa leaf powder, expands recall